Cytokinetics Inc (CYTK) · Insider trading
What Cytokinetics's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$51.97M
10 insiders, 91% under a plan
Net, 12 months
−$51.97M
bought less sold
Latest filing
2026-10-13
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Blum Robert IDirector, President & CEO | – | $25.38M | 42 | 2026-10-12 | 278,544 |
| Callos AndrewEVP, Chief Commercial Officer | – | $18.98M | 34 | 2026-08-31 | 58,555 |
| Malik Fady IbrahamEVP Research & Development | – | $8.47M | 51 | 2026-10-06 | 153,902 |
| Lee SungEVP, Chief Financial Officer | – | $5.70M | 5 | 2026-07-01 | 63,221 |
| Kaye Edward M. MDDirector | – | $3.66M | 7 | 2026-06-01 | 10,283 |
| Henderson John TDirector | – | $2.29M | 4 | 2026-05-05 | 75,237 |
| Wierenga WendellDirector | – | $1.88M | 3 | 2026-05-05 | 32,637 |
| Parshall B LynneDirector | – | $1.36M | 4 | 2026-09-01 | 10,784 |
| Wierenga WendallDirector | – | $1.07M | 4 | 2025-04-21 | 24,848 |
| Harrington Robert ArthurDirector | – | $304,254 | 4 | 2025-12-01 | 18,542 |
| Landry Robert EDirector | – | $146,790 | 2 | 2026-09-15 | 8,184 |
| Bhanji MunaDirector | – | $43,227 | 1 | 2025-05-15 | 23,510 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | Blum Robert IDirector, President & CEO | Saleplan | 7,500 | 62.88 | $471,600 | 278,544 | Form 4 |
| 2026-10-06 | Malik Fady IbrahamEVP Research & Development | Saleplan | 3,500 | 61.38 | $214,830 | 153,902 | Form 4 |
| 2026-09-28 | Blum Robert IDirector, President & CEO | Saleplan | 7,500 | 65.46 | $490,950 | 278,544 | Form 4 |
| 2026-09-22 | Malik Fady IbrahamEVP Research & Development | Saleplan | 3,500 | 68.29 | $239,015 | 153,902 | Form 4 |
| 2026-09-15 | Blum Robert IDirector, President & CEO | Saleplanindirect | 97,926 | 69.33 | $6.79M | 0 | Form 4 |
| 2026-09-15 | Landry Robert EDirector | Saleplan | 1,000 | 72.13 | $72,130 | 8,184 | Form 4 |
| 2026-09-14 | Blum Robert IDirector, President & CEO | Saleplan | 7,500 | 73.44 | $550,800 | 377,820 | Form 4 |
| 2026-09-11 | Landry Robert EDirector | Saleplan | 1,000 | 74.66 | $74,660 | 9,184 | Form 4 |
| 2026-09-08 | Malik Fady IbrahamEVP Research & Development | Saleplan | 3,500 | 75.46 | $264,110 | 153,902 | Form 4 |
| 2026-09-01 | Parshall B LynneDirector | Saleplan | 5,000 | 71.48 | $357,400 | 10,784 | Form 4 |
| 2026-08-31 | Blum Robert IDirector, President & CEO | Saleplan | 7,500 | 70.24 | $526,800 | 377,820 | Form 4 |
| 2026-08-31 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 10,000 | 70.24 | $702,400 | 58,555 | Form 4 |
| 2026-08-18 | Malik Fady IbrahamEVP Research & Development | Saleplan | 3,500 | 75.82 | $265,370 | 153,902 | Form 4 |
| 2026-08-10 | Blum Robert IDirector, President & CEO | Saleplan | 7,500 | 76.76 | $575,700 | 377,820 | Form 4 |
| 2026-07-30 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 14,000 | 79.88 | $1.12M | 58,555 | Form 4 |
| 2026-07-27 | Blum Robert IDirector, President & CEO | Saleplan | 7,500 | 80.87 | $606,525 | 377,820 | Form 4 |
| 2026-07-21 | Malik Fady IbrahamEVP Research & Development | Saleplan | 3,500 | 80.59 | $282,065 | 153,902 | Form 4 |
| 2026-07-13 | Blum Robert IDirector, President & CEO | Saleplan | 10 | 82.02 | $820 | 377,820 | Form 4 |
| 2026-07-13 | Blum Robert IDirector, President & CEO | Saleplan | 7,490 | 82.02 | $614,330 | 377,820 | Form 4 |
| 2026-07-07 | Malik Fady IbrahamEVP Research & Development | Saleplan | 3,500 | 86.62 | $303,170 | 153,902 | Form 4 |
| 2026-07-01 | Lee SungEVP, Chief Financial Officer | Saleplan | 1,112 | 87.79 | $97,622 | 63,221 | Form 4 |
| 2026-07-01 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 15,000 | 85.80 | $1.29M | 58,555 | Form 4 |
| 2026-07-01 | Blum Robert IDirector, President & CEO | Saleplan | 7,500 | 84.92 | $636,900 | 377,830 | Form 4 |
| 2026-06-29 | Lee SungEVP, Chief Financial Officer | Saleplan | 3,134 | 85.00 | $266,390 | 63,221 | Form 4 |
| 2026-06-24 | Lee SungEVP, Chief Financial Officer | Saleplan | 38,730 | 82.30 | $3.19M | 63,221 | Form 4 |
| 2026-06-23 | Malik Fady IbrahamEVP Research & Development | Saleplan | 3,500 | 79.51 | $278,285 | 153,902 | Form 4 |
| 2026-06-15 | Blum Robert IDirector, President & CEO | Saleplan | 7,500 | 70.46 | $528,450 | 385,330 | Form 4 |
| 2026-06-09 | Malik Fady IbrahamEVP Research & Development | Saleplan | 3,500 | 67.98 | $237,930 | 153,902 | Form 4 |
| 2026-06-01 | Parshall B LynneDirector | Saleplan | 5,000 | 74.08 | $370,400 | 15,784 | Form 4 |
| 2026-06-01 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 15,000 | 74.08 | $1.11M | 58,555 | Form 4 |
| 2026-06-01 | Kaye Edward M. MDDirector | Saleplan | 2,933 | 76.09 | $223,172 | 10,283 | Form 4 |
| 2026-05-27 | Blum Robert IDirector, President & CEO | Saleplan | 7,500 | 77.21 | $579,075 | 392,830 | Form 4 |
| 2026-05-19 | Malik Fady IbrahamEVP Research & Development | Saleplan | 3,500 | 75.69 | $264,915 | 153,902 | Form 4 |
| 2026-05-14 | Blum Robert IDirector, President & CEO | Saleplan | 7,500 | 77.92 | $584,400 | 400,330 | Form 4 |
| 2026-05-05 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 11,333 | 77.25 | $875,474 | 58,555 | Form 4 |
| 2026-05-05 | Henderson John TDirector | Saleplan | 20,000 | 75.97 | $1.52M | 75,237 | Form 4 |
| 2026-05-05 | Lee SungEVP, Chief Financial Officer | Saleplan | 23,906 | 76.87 | $1.84M | 63,221 | Form 4 |
| 2026-05-05 | Wierenga WendellDirector | Saleplan | 4,032 | 75.00 | $302,400 | 32,637 | Form 4 |
| 2026-05-05 | Malik Fady IbrahamEVP Research & Development | Saleplan | 3,500 | 77.37 | $270,795 | 153,902 | Form 4 |
| 2026-05-01 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 15,857 | 65.00 | $1.03M | 58,555 | Form 4 |
121 more
| 2026-04-30 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 15,000 | 63.26 | $948,900 | 58,555 | Form 4 |
| 2026-04-29 | Blum Robert IDirector, President & CEO | Saleplan | 7,500 | 59.62 | $447,150 | 407,830 | Form 4 |
| 2026-04-21 | Malik Fady IbrahamEVP Research & Development | Saleplan | 3,500 | 65.69 | $229,915 | 153,902 | Form 4 |
| 2026-04-15 | Blum Robert IDirector, President & CEO | Saleplan | 7,500 | 65.38 | $490,350 | 415,330 | Form 4 |
| 2026-04-15 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 7,449 | 66.02 | $491,783 | 58,555 | Form 4 |
| 2026-04-07 | Malik Fady IbrahamEVP Research & Development | Saleplan | 3,500 | 65.21 | $228,235 | 153,902 | Form 4 |
| 2026-04-07 | Malik Fady IbrahamEVP Research & Development | Saleplan | 1,000 | 64.75 | $64,750 | 153,902 | Form 4 |
| 2026-04-01 | Blum Robert IDirector, President & CEO | Saleplan | 7,500 | 66.63 | $499,725 | 422,830 | Form 4 |
| 2026-03-31 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 3,639 | 65.00 | $236,535 | 66,004 | Form 4 |
| 2026-03-18 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 1,930 | 62.07 | $119,795 | 78,185 | Form 4 |
| 2026-03-17 | Blum Robert IDirector, President & CEO | Sale | 12,673 | 62.15 | $787,627 | 454,258 | Form 4 |
| 2026-03-17 | Blum Robert IDirector, President & CEO | Sale | 23,928 | 62.15 | $1.49M | 430,330 | Form 4 |
| 2026-03-17 | Malik Fady IbrahamEVP Research & Development | Sale | 7,636 | 62.15 | $474,577 | 158,299 | Form 4 |
| 2026-03-17 | Malik Fady IbrahamEVP Research & Development | Sale | 4,397 | 62.15 | $273,274 | 153,902 | Form 4 |
| 2026-03-17 | Callos AndrewEVP, Chief Commercial Officer | Sale | 5,626 | 62.15 | $349,656 | 74,489 | Form 4 |
| 2026-03-17 | Callos AndrewEVP, Chief Commercial Officer | Sale | 2,916 | 62.15 | $181,229 | 71,573 | Form 4 |
| 2026-03-17 | Lee SungEVP, Chief Financial Officer | Sale | 4,935 | 62.15 | $306,710 | 87,127 | Form 4 |
| 2026-03-16 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 1,709 | 61.03 | $104,300 | 46,149 | Form 4 |
| 2026-03-09 | Blum Robert IDirector, President & CEO | Sale | 7,931 | 60.72 | $481,570 | 391,673 | Form 4 |
| 2026-03-09 | Malik Fady IbrahamEVP Research & Development | Sale | 2,907 | 60.72 | $176,513 | 138,629 | Form 4 |
| 2026-03-09 | Callos AndrewEVP, Chief Commercial Officer | Sale | 2,582 | 60.72 | $156,779 | 47,858 | Form 4 |
| 2026-03-05 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 15,000 | 61.87 | $928,050 | 61,440 | Form 4 |
| 2026-03-05 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 11,000 | 61.88 | $680,680 | 50,440 | Form 4 |
| 2026-03-02 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 886 | 61.62 | $54,595 | 50,440 | Form 4 |
| 2026-03-02 | Parshall B LynneDirector | Saleplan | 5,000 | 61.21 | $306,050 | 17,933 | Form 4 |
| 2026-02-05 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 15,000 | 61.93 | $928,950 | 50,440 | Form 4 |
| 2026-02-02 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 886 | 62.10 | $55,021 | 50,440 | Form 4 |
| 2026-01-05 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 15,000 | 60.28 | $904,200 | 50,440 | Form 4 |
| 2026-01-02 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 913 | 62.09 | $56,688 | 50,440 | Form 4 |
| 2026-01-02 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 885 | 63.16 | $55,897 | 50,440 | Form 4 |
| 2025-12-29 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 1,809 | 62.44 | $112,954 | 51,353 | Form 4 |
| 2025-12-22 | Wierenga WendellDirector | Saleplan | 20,000 | 66.14 | $1.32M | 32,444 | Form 4 |
| 2025-12-16 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,200 | 61.24 | $134,728 | 138,552 | Form 4 |
| 2025-12-08 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 1,042 | 65.96 | $68,730 | 50,660 | Form 4 |
| 2025-12-05 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 52,486 | 65.95 | $3.46M | 50,660 | Form 4 |
| 2025-12-02 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,200 | 63.89 | $140,558 | 140,610 | Form 4 |
| 2025-12-02 | Henderson John TDirector | Saleplan | 8,750 | 63.90 | $559,125 | 74,578 | Form 4 |
| 2025-12-01 | Harrington Robert ArthurDirector | Saleplan | 2,150 | 66.80 | $143,620 | 18,542 | Form 4 |
| 2025-12-01 | Kaye Edward M. MDDirector | Saleplan | 28,064 | 66.72 | $1.87M | 9,977 | Form 4 |
| 2025-11-19 | Parshall B LynneDirector | Saleplan | 5,000 | 64.73 | $323,650 | 22,933 | Form 4 |
| 2025-11-18 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,200 | 66.45 | $146,190 | 140,610 | Form 4 |
| 2025-11-11 | Kaye Edward M. MDDirector | Saleplan | 5,175 | 65.08 | $336,789 | 9,977 | Form 4 |
| 2025-11-04 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,295 | 59.55 | $136,667 | 140,610 | Form 4 |
| 2025-10-30 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 62.86 | $314,300 | 358,108 | Form 4 |
| 2025-10-27 | Wierenga WendellDirector | Saleplan | 4,375 | 58.68 | $256,725 | 32,444 | Form 4 |
| 2025-10-21 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,105 | 58.22 | $122,553 | 140,610 | Form 4 |
| 2025-10-16 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 60.03 | $300,150 | 363,108 | Form 4 |
| 2025-10-07 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 60.56 | $121,120 | 140,610 | Form 4 |
| 2025-10-06 | Kaye Edward M. MDDirector | Saleplan | 6,757 | 60.00 | $405,420 | 9,778 | Form 4 |
| 2025-10-01 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 55.05 | $275,250 | 368,108 | Form 4 |
| 2025-09-30 | Kaye Edward M. MDDirector | Saleplan | 6,695 | 55.08 | $368,761 | 16,535 | Form 4 |
| 2025-09-23 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 49.28 | $98,560 | 140,610 | Form 4 |
| 2025-09-15 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 49.77 | $248,850 | 373,108 | Form 4 |
| 2025-09-09 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 51.29 | $102,580 | 140,610 | Form 4 |
| 2025-09-02 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 48.76 | $243,800 | 378,108 | Form 4 |
| 2025-09-02 | Harrington Robert ArthurDirector | Saleplan | 2,150 | 48.67 | $104,640 | 20,493 | Form 4 |
| 2025-09-02 | Kaye Edward M. MDDirector | Saleplan | 6,756 | 50.00 | $337,800 | 23,230 | Form 4 |
| 2025-08-19 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 38.31 | $76,620 | 140,610 | Form 4 |
| 2025-08-15 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 38.42 | $192,100 | 383,108 | Form 4 |
| 2025-08-05 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 36.34 | $72,680 | 140,610 | Form 4 |
| 2025-07-29 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 36.45 | $182,250 | 388,108 | Form 4 |
| 2025-07-22 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 37.47 | $74,940 | 140,610 | Form 4 |
| 2025-07-14 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 38.15 | $190,750 | 393,108 | Form 4 |
| 2025-07-08 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 33.76 | $67,520 | 140,610 | Form 4 |
| 2025-07-01 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 33.55 | $167,750 | 398,108 | Form 4 |
| 2025-06-17 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 32.91 | $65,820 | 140,610 | Form 4 |
| 2025-06-16 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 33.80 | $169,000 | 403,108 | Form 4 |
| 2025-06-05 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 8,659 | 32.04 | $277,434 | 52,028 | Form 4 |
| 2025-06-05 | Kaye Edward M. MDDirector | Saleplan | 3,636 | 32.10 | $116,716 | 29,658 | Form 4 |
| 2025-06-03 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 31.88 | $63,760 | 140,610 | Form 4 |
| 2025-06-02 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 31.22 | $156,100 | 408,108 | Form 4 |
| 2025-05-20 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 31.98 | $63,960 | 140,255 | Form 4 |
| 2025-05-16 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 30.93 | $154,650 | 412,629 | Form 4 |
| 2025-05-15 | Bhanji MunaDirector | Saleplan | 1,454 | 29.73 | $43,227 | 23,510 | Form 4 |
| 2025-05-06 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 35.01 | $70,020 | 140,255 | Form 4 |
| 2025-05-05 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 4,002 | 36.68 | $146,793 | 60,687 | Form 4 |
| 2025-04-29 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 40.96 | $204,800 | 417,629 | Form 4 |
| 2025-04-22 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 38.11 | $76,220 | 140,255 | Form 4 |
| 2025-04-21 | Wierenga WendallDirector | Saleplan | 20,000 | 38.46 | $769,200 | 24,848 | Form 4 |
| 2025-04-15 | Henderson John TDirector | Saleplan | 3,190 | 38.66 | $123,325 | 66,348 | Form 4 |
| 2025-04-10 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 36.77 | $183,850 | 422,629 | Form 4 |
| 2025-04-08 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 36.18 | $72,360 | 140,255 | Form 4 |
| 2025-04-07 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 2,886 | 35.78 | $103,261 | 64,689 | Form 4 |
| 2025-04-03 | Harrington Robert ArthurDirector | Saleplan | 450 | 39.43 | $17,744 | 14,658 | Form 4 |
| 2025-03-31 | Blum Robert IDirector, President & CEO | Saleplan | 15,000 | 40.75 | $611,250 | 427,629 | Form 4 |
| 2025-03-18 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 43.58 | $87,160 | 140,455 | Form 4 |
| 2025-03-17 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 20,900 | 45.14 | $943,426 | 37,663 | Form 4 |
| 2025-03-17 | Blum Robert IDirector, President & CEO | Saleplan | 25,000 | 44.65 | $1.12M | 339,181 | Form 4 |
| 2025-03-17 | Blum Robert IDirector, President & CEO | Sale | 12,648 | 44.38 | $561,318 | 326,533 | Form 4 |
| 2025-03-17 | Malik Fady IbrahamEVP Research & Development | Sale | 4,389 | 44.38 | $194,784 | 101,005 | Form 4 |
| 2025-03-17 | Callos AndrewEVP, Chief Commercial Officer | Sale | 2,775 | 44.38 | $123,154 | 34,888 | Form 4 |
| 2025-03-14 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 100 | 45.00 | $4,500 | 37,663 | Form 4 |
| 2025-03-13 | Callos AndrewEVP, Chief Commercial Officer | Saleplan | 26,771 | 43.62 | $1.17M | 37,663 | Form 4 |
| 2025-03-06 | Blum Robert IDirector, President & CEO | Sale | 16,970 | 43.44 | $737,177 | 364,181 | Form 4 |
| 2025-03-06 | Malik Fady IbrahamEVP Research & Development | Sale | 8,228 | 43.27 | $356,026 | 105,394 | Form 4 |
| 2025-03-06 | Callos AndrewEVP, Chief Commercial Officer | Sale | 3,341 | 43.27 | $144,565 | 64,434 | Form 4 |
| 2025-03-05 | Blum Robert IDirector, President & CEO | Saleplan | 25,000 | 43.23 | $1.08M | 381,151 | Form 4 |
| 2025-03-04 | Harrington Robert ArthurDirector | Saleplan | 900 | 42.50 | $38,250 | 15,108 | Form 4 |
| 2025-03-04 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 42.50 | $85,000 | 116,071 | Form 4 |
| 2025-03-03 | Blum Robert IDirector, President & CEO | Sale | 8,743 | 42.88 | $374,900 | 406,151 | Form 4 |
| 2025-03-03 | Callos AndrewEVP, Chief Commercial Officer | Sale | 1,114 | 42.88 | $47,768 | 67,775 | Form 4 |
| 2025-03-03 | Malik Fady IbrahamEVP Research & Development | Sale | 2,449 | 42.88 | $105,013 | 113,622 | Form 4 |
| 2025-02-18 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 45.98 | $91,960 | 116,071 | Form 4 |
| 2025-02-04 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 48.06 | $96,120 | 116,071 | Form 4 |
| 2025-01-21 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 45.92 | $91,840 | 116,071 | Form 4 |
| 2025-01-07 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 49.32 | $98,640 | 116,071 | Form 4 |
| 2024-12-16 | Wierenga WendallDirector | Saleplan | 742 | 48.61 | $36,069 | 24,559 | Form 4 |
| 2024-12-11 | Henderson John TDirector | Saleplan | 1,780 | 50.42 | $89,748 | 38,461 | Form 4 |
| 2024-12-10 | Malik Fady IbrahamEVP Research & Development | Saleplan | 5,300 | 50.63 | $268,339 | 118,071 | Form 4 |
| 2024-12-10 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 50.65 | $101,300 | 116,071 | Form 4 |
| 2024-12-02 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 50.76 | $253,800 | 397,678 | Form 4 |
| 2024-11-26 | Malik Fady IbrahamEVP Research & Development | Saleplan | 5,300 | 50.17 | $265,901 | 113,878 | Form 4 |
| 2024-11-26 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 50.14 | $100,280 | 111,878 | Form 4 |
| 2024-11-25 | Wierenga WendallDirector | Saleplan | 742 | 50.00 | $37,100 | 24,559 | Form 4 |
| 2024-11-18 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 50.55 | $252,750 | 397,456 | Form 4 |
| 2024-11-12 | Malik Fady IbrahamEVP Research & Development | Saleplan | 5,300 | 58.48 | $309,944 | 114,920 | Form 4 |
| 2024-11-12 | Malik Fady IbrahamEVP Research & Development | Saleplan | 1,042 | 58.48 | $60,936 | 113,878 | Form 4 |
| 2024-11-01 | Blum Robert IDirector, President & CEO | Saleplan | 5,000 | 51.63 | $258,150 | 397,456 | Form 4 |
| 2024-10-30 | Malik Fady IbrahamEVP Research & Development | Saleplan | 5,300 | 51.90 | $275,070 | 116,920 | Form 4 |
| 2024-10-30 | Malik Fady IbrahamEVP Research & Development | Saleplan | 2,000 | 51.93 | $103,860 | 114,920 | Form 4 |
| 2024-10-28 | Wierenga WendallDirector | Saleplan | 4,452 | 52.25 | $232,617 | 24,559 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
102 × option exercise84 × grant or award15 × shares withheld for tax5 × gift
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-10-12 | Blum Robert IDirector, President & CEO | Option exercise M | +7,500 | 10.60 | 286,044 | Form 4 |
| 2026-10-06 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +3,500 | 7.80 | 157,402 | Form 4 |
| 2026-09-28 | Blum Robert IDirector, President & CEO | Option exercise M | +7,500 | 10.60 | 286,044 | Form 4 |
| 2026-09-22 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +3,500 | 7.80 | 157,402 | Form 4 |
| 2026-09-14 | Blum Robert IDirector, President & CEO | Option exercise M | +7,500 | 10.60 | 385,320 | Form 4 |
| 2026-09-14 | Blum Robert IDirector, President & CEO | Gift G | −1,350 | – | 376,470 | Form 4 |
| 2026-09-14 | Blum Robert IDirector, President & CEO | Gift G | −97,926 | – | 278,544 | Form 4 |
| 2026-09-14 | Blum Robert IDirector, President & CEO | Gift G | +97,926 | – | 97,926 | Form 4 |
| 2026-09-08 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +3,500 | 7.80 | 157,402 | Form 4 |
| 2026-08-31 | Blum Robert IDirector, President & CEO | Option exercise M | +7,500 | 10.60 | 385,320 | Form 4 |
| 2026-08-31 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +10,000 | 23.26 | 68,555 | Form 4 |
| 2026-08-18 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +3,500 | 7.80 | 157,402 | Form 4 |
| 2026-08-10 | Blum Robert IDirector, President & CEO | Option exercise M | +7,500 | 10.60 | 385,320 | Form 4 |
| 2026-07-30 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +14,000 | 23.26 | 72,555 | Form 4 |
| 2026-07-27 | Blum Robert IDirector, President & CEO | Option exercise M | +7,500 | 10.60 | 385,320 | Form 4 |
| 2026-07-21 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +3,500 | 7.80 | 157,402 | Form 4 |
| 2026-07-15 | Daly James MDirector | Grant or award A | +151 | 82.62 | 3,390 | Form 4 |
| 2026-07-15 | Harrington Robert ArthurDirector | Grant or award A | +151 | 82.62 | 21,932 | Form 4 |
| 2026-07-15 | Henderson John TDirector | Grant or award A | +272 | 82.62 | 78,360 | Form 4 |
| 2026-07-15 | Kaye Edward M. MDDirector | Grant or award A | +151 | 82.62 | 10,434 | Form 4 |
| 2026-07-15 | Wierenga WendellDirector | Grant or award A | +75 | 82.62 | 35,563 | Form 4 |
| 2026-07-15 | Wysenski NancyDirector | Grant or award A | +75 | 82.62 | 33,992 | Form 4 |
| 2026-07-13 | Blum Robert IDirector, President & CEO | Option exercise M | +7,490 | 10.60 | 385,310 | Form 4 |
| 2026-07-07 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +3,500 | 7.80 | 157,402 | Form 4 |
| 2026-07-01 | Lee SungEVP, Chief Financial Officer | Option exercise M | +1,112 | 48.51 | 64,333 | Form 4 |
| 2026-07-01 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +15,000 | 23.26 | 73,555 | Form 4 |
| 2026-06-29 | Lee SungEVP, Chief Financial Officer | Option exercise M | +188 | 44.36 | 63,409 | Form 4 |
| 2026-06-29 | Lee SungEVP, Chief Financial Officer | Option exercise M | +822 | 44.36 | 64,231 | Form 4 |
| 2026-06-29 | Lee SungEVP, Chief Financial Officer | Option exercise M | +1,113 | 48.51 | 65,344 | Form 4 |
| 2026-06-29 | Lee SungEVP, Chief Financial Officer | Option exercise M | +188 | 44.36 | 65,532 | Form 4 |
| 2026-06-29 | Lee SungEVP, Chief Financial Officer | Option exercise M | +823 | 44.36 | 66,355 | Form 4 |
| 2026-06-24 | Lee SungEVP, Chief Financial Officer | Option exercise M | +23,370 | 48.51 | 86,591 | Form 4 |
| 2026-06-24 | Lee SungEVP, Chief Financial Officer | Option exercise M | +9,307 | 44.36 | 95,898 | Form 4 |
| 2026-06-24 | Lee SungEVP, Chief Financial Officer | Option exercise M | +2,817 | 44.36 | 98,715 | Form 4 |
| 2026-06-24 | Lee SungEVP, Chief Financial Officer | Option exercise M | +1,113 | 48.51 | 99,828 | Form 4 |
| 2026-06-24 | Lee SungEVP, Chief Financial Officer | Option exercise M | +188 | 44.36 | 100,016 | Form 4 |
| 2026-06-24 | Lee SungEVP, Chief Financial Officer | Option exercise M | +822 | 44.36 | 100,838 | Form 4 |
| 2026-06-24 | Lee SungEVP, Chief Financial Officer | Option exercise M | +1,113 | 48.51 | 101,951 | Form 4 |
| 2026-06-23 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +3,500 | 7.80 | 157,402 | Form 4 |
| 2026-06-09 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +3,500 | 7.80 | 157,402 | Form 4 |
| 2026-06-01 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +15,000 | 23.26 | 73,555 | Form 4 |
| 2026-05-27 | Wysenski NancyDirector | Grant or award A | +2,851 | – | 33,917 | Form 4 |
| 2026-05-27 | Wierenga WendellDirector | Grant or award A | +2,851 | – | 35,488 | Form 4 |
| 2026-05-27 | Landry Robert EDirector | Grant or award A | +2,851 | – | 10,184 | Form 4 |
| 2026-05-27 | Parshall B LynneDirector | Grant or award A | +2,851 | – | 20,784 | Form 4 |
| 2026-05-27 | Kaye Edward M. MDDirector | Grant or award A | +2,851 | – | 13,216 | Form 4 |
| 2026-05-27 | Henderson John TDirector | Grant or award A | +2,851 | – | 78,088 | Form 4 |
| 2026-05-27 | Harrington Robert ArthurDirector | Grant or award A | +2,851 | – | 21,781 | Form 4 |
| 2026-05-27 | Daly James MDirector | Grant or award A | +2,851 | – | 3,239 | Form 4 |
| 2026-05-27 | Bhanji MunaDirector | Grant or award A | +2,851 | – | 26,361 | Form 4 |
| 2026-05-19 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +3,500 | 7.80 | 157,402 | Form 4 |
| 2026-05-05 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +11,333 | 39.13 | 69,888 | Form 4 |
| 2026-05-05 | Henderson John TDirector | Option exercise M | +20,000 | 7.61 | 95,237 | Form 4 |
| 2026-05-05 | Wierenga WendellDirector | Option exercise M | +4,032 | 12.40 | 36,669 | Form 4 |
| 2026-05-05 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +3,500 | 7.80 | 157,402 | Form 4 |
| 2026-05-01 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +15,857 | 37.63 | 74,412 | Form 4 |
| 2026-04-30 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +15,000 | 23.26 | 73,555 | Form 4 |
| 2026-04-21 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +3,500 | 7.80 | 157,402 | Form 4 |
| 2026-04-15 | Daly James MDirector | Grant or award A | +191 | 65.37 | 388 | Form 4 |
| 2026-04-15 | Harrington Robert ArthurDirector | Grant or award A | +191 | 65.37 | 18,930 | Form 4 |
| 2026-04-15 | Henderson John TDirector | Grant or award A | +325 | 65.37 | 75,237 | Form 4 |
| 2026-04-15 | Kaye Edward M. MDDirector | Grant or award A | +191 | 65.37 | 10,365 | Form 4 |
| 2026-04-15 | Wierenga WendellDirector | Grant or award A | +95 | 65.37 | 32,637 | Form 4 |
| 2026-04-15 | Wysenski NancyDirector | Grant or award A | +95 | 65.37 | 31,066 | Form 4 |
| 2026-04-07 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +3,500 | 7.80 | 157,402 | Form 4 |
| 2026-04-07 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +1,000 | 10.60 | 154,902 | Form 4 |
| 2026-03-15 | Malik Fady IbrahamEVP Research & Development | Grant or award A | +27,306 | – | 165,935 | Form 4 |
| 2026-03-15 | Lee SungEVP, Chief Financial Officer | Grant or award A | +20,646 | – | 92,062 | Form 4 |
| 2026-03-15 | Hessekiel JeffreyChief Legal & Admin Officer | Grant or award A | +20,646 | – | 107,943 | Form 4 |
| 2026-03-15 | Callos AndrewEVP, Chief Commercial Officer | Grant or award A | +20,646 | – | 68,504 | Form 4 |
| 2026-03-15 | Callos AndrewEVP, Chief Commercial Officer | Grant or award A | +13,320 | – | 81,824 | Form 4 |
| 2026-03-15 | Blum Robert IDirector, President & CEO | Grant or award A | +75,258 | – | 466,931 | Form 4 |
| 2026-03-05 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +11,000 | 39.13 | 76,440 | Form 4 |
| 2026-03-05 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +15,000 | 23.26 | 65,440 | Form 4 |
| 2026-03-02 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +886 | 37.63 | 51,326 | Form 4 |
| 2026-02-05 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +15,000 | 23.26 | 65,440 | Form 4 |
| 2026-02-02 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +886 | 37.63 | 51,326 | Form 4 |
| 2026-01-15 | Daly James MDirector | Grant or award A | +197 | 63.44 | 197 | Form 4 |
| 2026-01-15 | Harrington Robert ArthurDirector | Grant or award A | +197 | 63.44 | 18,739 | Form 4 |
| 2026-01-15 | Henderson John TDirector | Grant or award A | +334 | 63.44 | 74,912 | Form 4 |
| 2026-01-15 | Kaye Edward M. MDDirector | Grant or award A | +197 | 63.44 | 10,174 | Form 4 |
| 2026-01-15 | Wierenga WendellDirector | Grant or award A | +98 | 63.44 | 32,542 | Form 4 |
| 2026-01-15 | Wysenski NancyDirector | Grant or award A | +98 | 63.44 | 30,971 | Form 4 |
| 2026-01-05 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +15,000 | 23.26 | 65,440 | Form 4 |
| 2026-01-02 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +885 | 37.63 | 51,325 | Form 4 |
| 2025-12-22 | Lee SungEVP, Chief Financial Officer | Grant or award A | +2,152 | – | 70,069 | Form 4 |
| 2025-12-22 | Lee SungEVP, Chief Financial Officer | Grant or award A | +2,152 | – | 72,221 | Form 4 |
| 2025-12-22 | Lee SungEVP, Chief Financial Officer | Shares withheld for tax F | −805 | 62.72 | 71,416 | Form 4 |
| 2025-12-22 | Callos AndrewEVP, Chief Commercial Officer | Grant or award A | +1,589 | – | 52,249 | Form 4 |
| 2025-12-22 | Callos AndrewEVP, Chief Commercial Officer | Grant or award A | +1,588 | – | 53,837 | Form 4 |
| 2025-12-22 | Callos AndrewEVP, Chief Commercial Officer | Shares withheld for tax F | −675 | 62.72 | 53,162 | Form 4 |
| 2025-12-22 | Malik Fady IbrahamEVP Research & Development | Grant or award A | +2,000 | – | 140,552 | Form 4 |
| 2025-12-22 | Malik Fady IbrahamEVP Research & Development | Grant or award A | +2,000 | – | 142,552 | Form 4 |
| 2025-12-22 | Malik Fady IbrahamEVP Research & Development | Shares withheld for tax F | −1,016 | 62.72 | 141,536 | Form 4 |
| 2025-12-22 | Blum Robert IDirector, President & CEO | Grant or award A | +5,765 | – | 396,774 | Form 4 |
| 2025-12-22 | Blum Robert IDirector, President & CEO | Grant or award A | +5,765 | – | 402,539 | Form 4 |
| 2025-12-22 | Blum Robert IDirector, President & CEO | Shares withheld for tax F | −2,935 | 62.72 | 399,604 | Form 4 |
| 2025-12-22 | Wierenga WendellDirector | Option exercise M | +20,000 | 7.61 | 52,444 | Form 4 |
| 2025-12-22 | Blum Robert IDirector, President & CEO | Option exercise M | +54,727 | 6.67 | 404,929 | Form 4 |
| 2025-12-22 | Blum Robert IDirector, President & CEO | Shares withheld for tax F | −30,426 | 68.18 | 374,503 | Form 4 |
| 2025-12-22 | Blum Robert IDirector, President & CEO | Option exercise M | +16,506 | 6.67 | 391,009 | Form 4 |
| 2025-12-16 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,200 | 10.60 | 140,752 | Form 4 |
| 2025-12-08 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +1,042 | 39.13 | 51,702 | Form 4 |
| 2025-12-05 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +15,000 | 23.26 | 65,660 | Form 4 |
| 2025-12-05 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +11,000 | 39.13 | 76,660 | Form 4 |
| 2025-12-05 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +15,858 | 37.63 | 92,518 | Form 4 |
| 2025-12-05 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +10,628 | 37.63 | 103,146 | Form 4 |
| 2025-12-03 | Blum Robert IDirector, President & CEO | Shares withheld for tax F | −5,930 | 65.02 | 350,202 | Form 4 |
| 2025-12-03 | Malik Fady IbrahamEVP Research & Development | Shares withheld for tax F | −2,058 | 65.02 | 138,552 | Form 4 |
| 2025-12-03 | Callos AndrewEVP, Chief Commercial Officer | Shares withheld for tax F | −1,368 | 65.02 | 50,660 | Form 4 |
| 2025-12-03 | Lee SungEVP, Chief Financial Officer | Shares withheld for tax F | −1,560 | 65.02 | 67,917 | Form 4 |
| 2025-12-02 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,200 | 10.60 | 142,810 | Form 4 |
| 2025-12-02 | Henderson John TDirector | Option exercise M | +8,750 | 10.00 | 83,328 | Form 4 |
| 2025-12-01 | Kaye Edward M. MDDirector | Option exercise M | +8,064 | 12.40 | 18,041 | Form 4 |
| 2025-12-01 | Kaye Edward M. MDDirector | Option exercise M | +20,000 | 14.25 | 38,041 | Form 4 |
| 2025-11-18 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,200 | 10.60 | 142,810 | Form 4 |
| 2025-11-14 | Hessekiel JeffreyChief Legal & Admin Officer | Grant or award A | +87,297 | – | 87,297 | Form 4 |
| 2025-11-11 | Kaye Edward M. MDDirector | Option exercise M | +5,175 | 9.66 | 15,152 | Form 4 |
| 2025-11-05 | Blum Robert IDirector, President & CEO | Gift G | −2,000 | – | 356,108 | Form 4 |
| 2025-11-04 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,295 | 10.60 | 142,905 | Form 4 |
| 2025-10-27 | Wierenga WendellDirector | Option exercise M | +4,375 | 10.00 | 36,819 | Form 4 |
| 2025-10-21 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,105 | 10.60 | 142,715 | Form 4 |
| 2025-10-15 | Wierenga WendellDirector | Grant or award A | +99 | 62.80 | 32,444 | Form 4 |
| 2025-10-15 | Wysenski NancyDirector | Grant or award A | +99 | 62.80 | 30,873 | Form 4 |
| 2025-10-15 | Kaye Edward M. MDDirector | Grant or award A | +199 | 62.80 | 9,977 | Form 4 |
| 2025-10-15 | Henderson John TDirector | Grant or award A | +338 | 62.80 | 74,578 | Form 4 |
| 2025-10-15 | Harrington Robert ArthurDirector | Grant or award A | +199 | 62.80 | 20,692 | Form 4 |
| 2025-10-07 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,610 | Form 4 |
| 2025-09-23 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,610 | Form 4 |
| 2025-09-09 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,610 | Form 4 |
| 2025-08-19 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,610 | Form 4 |
| 2025-08-05 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,610 | Form 4 |
| 2025-07-22 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,610 | Form 4 |
| 2025-07-15 | Harrington Robert ArthurDirector | Grant or award A | +328 | 38.01 | 22,643 | Form 4 |
| 2025-07-15 | Kaye Edward M. MDDirector | Grant or award A | +328 | 38.01 | 29,986 | Form 4 |
| 2025-07-15 | Wierenga WendallDirector | Grant or award A | +164 | 38.01 | 32,345 | Form 4 |
| 2025-07-15 | Wysenski NancyDirector | Grant or award A | +164 | 38.01 | 30,774 | Form 4 |
| 2025-07-15 | Henderson John TDirector | Grant or award A | +559 | 38.01 | 74,240 | Form 4 |
| 2025-07-08 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,610 | Form 4 |
| 2025-06-17 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,610 | Form 4 |
| 2025-06-03 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,610 | Form 4 |
| 2025-06-02 | Lee SungEVP, Chief Financial Officer | Shares withheld for tax F | −4,965 | 31.21 | 69,477 | Form 4 |
| 2025-05-20 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,255 | Form 4 |
| 2025-05-14 | Harrington Robert ArthurDirector | Grant or award A | +7,333 | – | 22,315 | Form 4 |
| 2025-05-14 | Parshall B LynneDirector | Grant or award A | +7,333 | – | 27,933 | Form 4 |
| 2025-05-14 | Wysenski NancyDirector | Grant or award A | +7,333 | – | 30,610 | Form 4 |
| 2025-05-14 | Wierenga WendallDirector | Grant or award A | +7,333 | – | 32,181 | Form 4 |
| 2025-05-14 | Landry Robert EDirector | Grant or award A | +7,333 | – | 7,333 | Form 4 |
| 2025-05-14 | Kaye Edward M. MDDirector | Grant or award A | +7,333 | – | 33,294 | Form 4 |
| 2025-05-14 | Henderson John TDirector | Grant or award A | +7,333 | – | 73,681 | Form 4 |
| 2025-05-14 | Bhanji MunaDirector | Grant or award A | +7,333 | – | 24,964 | Form 4 |
| 2025-05-06 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,255 | Form 4 |
| 2025-04-22 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,255 | Form 4 |
| 2025-04-21 | Wierenga WendallDirector | Option exercise M | +20,000 | 6.21 | 44,848 | Form 4 |
| 2025-04-15 | Wysenski NancyDirector | Grant or award A | +162 | 38.56 | 23,277 | Form 4 |
| 2025-04-15 | Wierenga WendallDirector | Grant or award A | +162 | 38.56 | 24,848 | Form 4 |
| 2025-04-15 | Kaye Edward M. MDDirector | Grant or award A | +324 | 38.56 | 25,961 | Form 4 |
| 2025-04-15 | Harrington Robert ArthurDirector | Grant or award A | +324 | 38.56 | 14,982 | Form 4 |
| 2025-04-15 | Henderson John TDirector | Grant or award A | +551 | 38.56 | 66,348 | Form 4 |
| 2025-04-15 | Henderson John TDirector | Option exercise M | +20,000 | 6.21 | 69,538 | Form 4 |
| 2025-04-08 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,255 | Form 4 |
| 2025-03-19 | Malik Fady IbrahamEVP Research & Development | Gift G | −200 | – | 140,255 | Form 4 |
| 2025-03-18 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 142,455 | Form 4 |
| 2025-03-17 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +20,900 | 23.26 | 58,563 | Form 4 |
| 2025-03-14 | Blum Robert IDirector, President & CEO | Grant or award A | +116,096 | – | 480,277 | Form 4 |
| 2025-03-14 | Malik Fady IbrahamEVP Research & Development | Grant or award A | +39,450 | – | 144,844 | Form 4 |
| 2025-03-14 | Callos AndrewEVP, Chief Commercial Officer | Grant or award A | +32,687 | – | 70,350 | Form 4 |
| 2025-03-14 | Lee SungEVP, Chief Financial Officer | Grant or award A | +32,687 | – | 74,442 | Form 4 |
| 2025-03-14 | Callos AndrewEVP, Chief Commercial Officer | Option exercise M | +100 | 23.26 | 37,763 | Form 4 |
| 2025-03-04 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 118,071 | Form 4 |
| 2025-02-18 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 118,071 | Form 4 |
| 2025-02-04 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 118,071 | Form 4 |
| 2025-01-21 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 118,071 | Form 4 |
| 2025-01-07 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +2,000 | 10.60 | 118,071 | Form 4 |
| 2025-01-02 | Wierenga WendallDirector | Grant or award A | +127 | 48.93 | 24,686 | Form 4 |
| 2025-01-02 | Wysenski NancyDirector | Grant or award A | +127 | 48.93 | 23,115 | Form 4 |
| 2025-01-02 | Kaye Edward M. MDDirector | Grant or award A | +255 | 48.93 | 25,637 | Form 4 |
| 2025-01-02 | Harrington Robert ArthurDirector | Grant or award A | +255 | 48.93 | 16,008 | Form 4 |
| 2025-01-02 | Henderson John TDirector | Grant or award A | +434 | 48.93 | 48,987 | Form 4 |
| 2024-12-16 | Wierenga WendallDirector | Option exercise M | +742 | 7.37 | 25,301 | Form 4 |
| 2024-12-11 | Henderson John TDirector | Option exercise M | +1,780 | 7.37 | 40,241 | Form 4 |
| 2024-12-11 | Henderson John TDirector | Option exercise M | +10,092 | 7.37 | 48,553 | Form 4 |
| 2024-12-10 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +5,300 | 7.96 | 123,371 | Form 4 |
| 2024-12-03 | Blum Robert IDirector, President & CEO | Grant or award A | +11,529 | – | 409,207 | Form 4 |
| 2024-12-03 | Blum Robert IDirector, President & CEO | Shares withheld for tax F | −5,843 | 51.51 | 403,364 | Form 4 |
| 2024-12-03 | Blum Robert IDirector, President & CEO | Grant or award A | +11,530 | – | 414,894 | Form 4 |
| 2024-12-03 | Callos AndrewEVP, Chief Commercial Officer | Grant or award A | +3,176 | – | 67,063 | Form 4 |
| 2024-12-03 | Callos AndrewEVP, Chief Commercial Officer | Shares withheld for tax F | −1,351 | 51.51 | 65,712 | Form 4 |
| 2024-12-03 | Callos AndrewEVP, Chief Commercial Officer | Grant or award A | +3,177 | – | 68,889 | Form 4 |
| 2024-12-03 | Malik Fady IbrahamEVP Research & Development | Grant or award A | +4,000 | – | 116,099 | Form 4 |
| 2024-12-03 | Malik Fady IbrahamEVP Research & Development | Shares withheld for tax F | −2,028 | 51.51 | 114,071 | Form 4 |
| 2024-12-03 | Malik Fady IbrahamEVP Research & Development | Grant or award A | +4,000 | – | 118,071 | Form 4 |
| 2024-12-03 | Lee SungEVP, Chief Financial Officer | Grant or award A | +4,303 | – | 38,987 | Form 4 |
| 2024-12-03 | Lee SungEVP, Chief Financial Officer | Shares withheld for tax F | −1,536 | 51.51 | 37,451 | Form 4 |
| 2024-12-03 | Lee SungEVP, Chief Financial Officer | Grant or award A | +4,304 | – | 41,755 | Form 4 |
| 2024-12-03 | Wong RobertVP, Chief Accounting Officer | Grant or award A | +764 | – | 18,162 | Form 4 |
| 2024-12-03 | Wong RobertVP, Chief Accounting Officer | Shares withheld for tax F | −273 | 51.51 | 17,889 | Form 4 |
| 2024-12-03 | Wong RobertVP, Chief Accounting Officer | Grant or award A | +766 | – | 18,655 | Form 4 |
| 2024-12-02 | Blum Robert IDirector, President & CEO | Option exercise M | +5,000 | 6.67 | 402,678 | Form 4 |
| 2024-11-26 | Malik Fady IbrahamEVP Research & Development | Option exercise M | +5,300 | 7.96 | 119,178 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.